Medindia

X

Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE

by Bidita Debnath on  November 8, 2015 at 2:18 AM Corporate News   - G J E 4
Pharmaceutical manufacturer Aurobindo Pharma said that it posted a standalone net profit of Rs.340.09 crore for the second quarter of 2015-16 against a net profit of Rs.391.66 crore in the same period last year, showing a 13.16 percent dip.
 Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE
Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE
Advertisement

According to the statement of standalone unaudited results posted on the Bombay Stock Exchange (BSE), the company's total income from operations rose to Rs.2,175.93 crore from Rs.2,007.70 crore while total expenditure increased to Rs.1,690.50 crore from Rs.1,468.66 crore.

‘Pharmaceutical manufacturer Aurobindo Pharma posted a net profit of Rs.451.76 crore in Q2 against Rs.372.18 crore, while total income from operations rose to Rs.3,333.43 crore from Rs.2,881.22 crore.’
Advertisement
On consolidated basis, Aurobindo Pharma posted a net profit of Rs.451.76 crore in Q2 against Rs.372.18 crore in the last quarter, while total income from operations rose to Rs.3,333.43 crore from Rs.2,881.22 crore.

Aurobindo Pharma incurred a total expenditure of Rs.2,650.65 crore in the reviewed quarter on a consolidated basis against Rs.2,333.86 crore in the previous quarter.

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: